vs
RIGEL PHARMACEUTICALS INC(RIGL)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍($78.6M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -178.3%,领先562.3%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 0.4%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs -1.3%)
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
RIGL vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出20.8%
0.4%
净利率更高
RIGL
高出562.3%
-178.3%
两年增速更快
RIGL
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $69.8M | $78.6M |
| 净利润 | $268.1M | $-140.1M |
| 毛利率 | 91.5% | 74.2% |
| 营业利润率 | 33.2% | -182.2% |
| 净利率 | 384.0% | -178.3% |
| 营收同比 | 21.2% | 0.4% |
| 净利润同比 | 1769.2% | -3304.1% |
| 每股收益(稀释后) | $14.11 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RIGL
RPAY
| Q4 25 | $69.8M | $78.6M | ||
| Q3 25 | $69.5M | $77.7M | ||
| Q2 25 | $101.7M | $75.6M | ||
| Q1 25 | $53.3M | $77.3M | ||
| Q4 24 | $57.6M | $78.3M | ||
| Q3 24 | $55.3M | $79.1M | ||
| Q2 24 | $36.8M | $74.9M | ||
| Q1 24 | $29.5M | $80.7M |
净利润
RIGL
RPAY
| Q4 25 | $268.1M | $-140.1M | ||
| Q3 25 | $27.9M | $-6.4M | ||
| Q2 25 | $59.6M | $-102.3M | ||
| Q1 25 | $11.4M | $-7.9M | ||
| Q4 24 | $14.3M | $-4.1M | ||
| Q3 24 | $12.4M | $3.2M | ||
| Q2 24 | $-1.0M | $-4.1M | ||
| Q1 24 | $-8.2M | $-5.2M |
毛利率
RIGL
RPAY
| Q4 25 | 91.5% | 74.2% | ||
| Q3 25 | 93.2% | 74.4% | ||
| Q2 25 | 95.6% | 75.7% | ||
| Q1 25 | 91.7% | 75.9% | ||
| Q4 24 | 89.9% | 76.3% | ||
| Q3 24 | 85.5% | 77.8% | ||
| Q2 24 | 92.4% | 78.2% | ||
| Q1 24 | 93.1% | 76.2% |
营业利润率
RIGL
RPAY
| Q4 25 | 33.2% | -182.2% | ||
| Q3 25 | 40.9% | -3.9% | ||
| Q2 25 | 60.1% | -138.7% | ||
| Q1 25 | 23.9% | -4.7% | ||
| Q4 24 | 28.9% | -1.5% | ||
| Q3 24 | 25.4% | -0.9% | ||
| Q2 24 | 1.2% | -4.6% | ||
| Q1 24 | -23.6% | -3.1% |
净利率
RIGL
RPAY
| Q4 25 | 384.0% | -178.3% | ||
| Q3 25 | 40.2% | -8.3% | ||
| Q2 25 | 58.6% | -135.2% | ||
| Q1 25 | 21.5% | -10.3% | ||
| Q4 24 | 24.9% | -5.3% | ||
| Q3 24 | 22.5% | 4.1% | ||
| Q2 24 | -2.8% | -5.4% | ||
| Q1 24 | -27.9% | -6.5% |
每股收益(稀释后)
RIGL
RPAY
| Q4 25 | $14.11 | $-1.68 | ||
| Q3 25 | $1.46 | $-0.08 | ||
| Q2 25 | $3.28 | $-1.15 | ||
| Q1 25 | $0.63 | $-0.09 | ||
| Q4 24 | $0.82 | $-0.04 | ||
| Q3 24 | $0.70 | $0.03 | ||
| Q2 24 | $-0.06 | $-0.04 | ||
| Q1 24 | $-0.47 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $155.0M | $115.7M |
| 总债务越低越好 | $52.5M | $280.1M |
| 股东权益账面价值 | $391.5M | $484.4M |
| 总资产 | $513.6M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.13× | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
RIGL
RPAY
| Q4 25 | $155.0M | $115.7M | ||
| Q3 25 | $137.1M | $95.7M | ||
| Q2 25 | $108.4M | $162.6M | ||
| Q1 25 | $77.1M | $165.5M | ||
| Q4 24 | $77.3M | $189.5M | ||
| Q3 24 | $61.1M | $168.7M | ||
| Q2 24 | $49.1M | $147.1M | ||
| Q1 24 | $49.5M | $128.3M |
总债务
RIGL
RPAY
| Q4 25 | $52.5M | $280.1M | ||
| Q3 25 | $60.0M | $279.5M | ||
| Q2 25 | $60.0M | $279.0M | ||
| Q1 25 | $60.0M | $497.6M | ||
| Q4 24 | $60.0M | $496.8M | ||
| Q3 24 | $60.0M | $496.2M | ||
| Q2 24 | $60.0M | $435.6M | ||
| Q1 24 | $60.0M | $434.9M |
股东权益
RIGL
RPAY
| Q4 25 | $391.5M | $484.4M | ||
| Q3 25 | $117.6M | $616.9M | ||
| Q2 25 | $81.9M | $633.7M | ||
| Q1 25 | $18.6M | $755.7M | ||
| Q4 24 | $3.3M | $761.3M | ||
| Q3 24 | $-14.6M | $754.7M | ||
| Q2 24 | $-29.9M | $815.4M | ||
| Q1 24 | $-31.7M | $813.8M |
总资产
RIGL
RPAY
| Q4 25 | $513.6M | $1.2B | ||
| Q3 25 | $242.5M | $1.3B | ||
| Q2 25 | $206.7M | $1.4B | ||
| Q1 25 | $176.0M | $1.5B | ||
| Q4 24 | $164.0M | $1.6B | ||
| Q3 24 | $139.4M | $1.6B | ||
| Q2 24 | $128.4M | $1.5B | ||
| Q1 24 | $126.5M | $1.5B |
负债/权益比
RIGL
RPAY
| Q4 25 | 0.13× | 0.58× | ||
| Q3 25 | 0.51× | 0.45× | ||
| Q2 25 | 0.73× | 0.44× | ||
| Q1 25 | 3.23× | 0.66× | ||
| Q4 24 | 18.25× | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $22.0M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | — | $23.2M |
| 自由现金流率自由现金流/营收 | — | 29.6% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | 0.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势,按日历期对齐
经营现金流
RIGL
RPAY
| Q4 25 | $22.0M | $23.3M | ||
| Q3 25 | $24.0M | $32.2M | ||
| Q2 25 | $30.5M | $33.1M | ||
| Q1 25 | $-893.0K | $2.5M | ||
| Q4 24 | $14.5M | $34.3M | ||
| Q3 24 | $21.7M | $60.1M | ||
| Q2 24 | $302.0K | $31.0M | ||
| Q1 24 | $-5.0M | $24.8M |
自由现金流
RIGL
RPAY
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率
RIGL
RPAY
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度
RIGL
RPAY
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
现金转化率
RIGL
RPAY
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | 1.01× | — | ||
| Q3 24 | 1.75× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RIGL
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |